Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Radiofrequency thermal ablation for pain control in patients with single painful bone metastasis from hepatocellular carcinoma
European Journal of Radiology, 08/11/09
Carrafiello G et al. – In a study to assess the safety and efficacy of radiofrequency thermal ablation (RFA) for pain relief and analgesics use reduction in 2 pts with painful bone metastases from hepatocellular carcinoma (HCC), it was found that RFA provides a potential alternative method for palliation of painful osteolytic metastases from HCC; the procedure is safe, and pain relief is substantial.
Methods- 2 pts with lytic metastases from HCC located at the left superior ileo-pubic branch and at the middle arch of VII rib, performed RFA displacing a LeVeen Needle (3.5 and 4.0cm diameter) under US (ultrasonography) and fluoroscopic guidance.
- 2 methods were used to determine response of both pts: the first method was to measure pt's worst pain with a Brief Pain Inventory (BPI) 1 day after the procedure, every wk for 1 mo, and thereafter at wk 8 and 12 (total follow-up 3 mos); the second method was to evaluate pt's analgesics use recorded at wk 1, 4, 8 and 12.
- Analgesic medication use was translated into a morphine-equivalent dose.
- RFA was well tolerated by the pts who did not develop any complication.
- Both patients obtained substantial reduction of pain, which decreased from a mean score of 8 to approximately 2 in 4 wks.
- In both pts, a reduction was observed in use of morphine dose-equivalent after a peak at wk 1.
- CT (computed tomography) imaging, performed at 1 mo after RFA, demonstrated that both procedures were technically successful and safe because consistent necrosis and no evidence for complications were observed.
Related Articles
Epidermal Growth Factor-Containing Fibulin-Like Extracellular Matrix Protein 1, EFEMP1, a Novel Tumor-Suppressor Gene Detected in Hepatocellular Carcinoma Using Double Combination Array Analysis
Annals of Surgical Oncology, 11/11/09
Relevance Score: 69%
Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma in 14 Patients Undergoing Regular Hemodialysis for End-Stage Renal Disease
American Journal of Roentgenology, 10/09/09
Relevance Score: 69%
Inhibitory effects of genistein on metastasis of human hepatocellular carcinoma
World Journal of Gastroenterology, 10/27/09
Relevance Score: 68%
Cryotherapy for hepatocellular carcinoma
Cochrane Reviews, 10/09/09
Relevance Score: 68%
MicroRNA expression, survival, and response to Interferon in liver cancer
New England Journal of Medicine, 10/08/09
Relevance Score: 68%
Today in Interventional...keeping you current
Receive free subspecialty "5-minute updates" via email
Prospective Randomized Comparison of Chemoembolization with Doxorubicin-Eluting Beads and Bland Embolization with BeadBlock for Hepatocellular Carcinoma
Cardiovascular and Interventional Radiology, 12/07/09
Leash Your Guiding Catheter: Or How to Obtain a Stable Catheter Position for Crossover Iliac Embolization Procedures
Cardiovascular and Interventional Radiology, 12/07/09
Quality Improvement Guidelines for Radiofrequency Ablation of Liver Tumours
Cardiovascular and Interventional Radiology, 12/07/09
Sponsor
Article Search
Sponsor


See Latest Articles


